Form 8.3 - INTERNATIONAL PAPER COMPANY

LONDON--()-- 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Qube Research & Technologies Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

International Paper Company

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

17-06-2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

Yes - DS Smith plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

Common Stock

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0

3,783,149

1.09

(2) Cash-settled derivatives:

 

0

0

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

400,000*

0.115

0

0

 

TOTAL:

400,000

0.115

0

0

*This long position relates to a reverse collar transaction. See supplemental form 8 for full details

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

0

Details, including nature of the rights concerned and relevant percentages:

0

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Common Stock

Purchase

100

44.61

Common Stock

Purchase

17

44.63

Common Stock

Purchase

100

44.655

Common Stock

Purchase

100

44.67

Common Stock

Purchase

111

44.69

Common Stock

Purchase

100

44.74

Common Stock

Purchase

60

44.75

Common Stock

Purchase

101

44.76

Common Stock

Purchase

146

44.79

Common Stock

Purchase

440

44.83

Common Stock

Purchase

187

44.9

Common Stock

Purchase

1100

44.95

Common Stock

Purchase

100

44.96

Common Stock

Purchase

43

44.99

Common Stock

Purchase

100

45

Common Stock

Purchase

8

45.05

Common Stock

Purchase

111

45.08

Common Stock

Purchase

42

45.11

Common Stock

Purchase

44

45.12

Common Stock

Purchase

19

45.16

Common Stock

Purchase

11

45.17

Common Stock

Purchase

514

45.18

Common Stock

Purchase

9

45.19

Common Stock

Purchase

111

45.21

Common Stock

Purchase

261

45.22

Common Stock

Purchase

53

45.23

Common Stock

Purchase

712

45.27

Common Stock

Purchase

207

45.28

Common Stock

Purchase

1000

45.29

Common Stock

Purchase

1046

45.3

Common Stock

Purchase

1834

45.31

Common Stock

Purchase

1228

45.32

Common Stock

Purchase

354

45.33

Common Stock

Purchase

144

45.34

Common Stock

Purchase

307

45.36

Common Stock

Purchase

1400

45.37

Common Stock

Purchase

150

45.39

Common Stock

Purchase

10

45.395

Common Stock

Purchase

391

45.4

Common Stock

Purchase

1

45.405

Common Stock

Purchase

29

45.41

Common Stock

Purchase

67

45.42

Common Stock

Purchase

12

45.44

Common Stock

Purchase

58

45.48

Common Stock

Purchase

31160

 

45.37

Common Stock

Sale

91

44.51

Common Stock

Sale

32

44.61

Common Stock

Sale

104

44.62

Common Stock

Sale

65

44.63

Common Stock

Sale

110

44.635

Common Stock

Sale

141

44.64

Common Stock

Sale

5

44.71

Common Stock

Sale

124

44.77

Common Stock

Sale

92

44.78

Common Stock

Sale

203

44.8

Common Stock

Sale

107

44.82

Common Stock

Sale

45

44.83

Common Stock

Sale

100

44.85

Common Stock

Sale

100

44.88

Common Stock

Sale

100

44.89

Common Stock

Sale

64

44.9

Common Stock

Sale

22

44.94

Common Stock

Sale

167

44.96

Common Stock

Sale

200

44.99

Common Stock

Sale

64

45

Common Stock

Sale

61

45.03

Common Stock

Sale

90

45.04

Common Stock

Sale

140

45.05

Common Stock

Sale

81

45.17

Common Stock

Sale

47

45.18

Common Stock

Sale

97

45.19

Common Stock

Sale

100

45.22

Common Stock

Sale

23

45.23

Common Stock

Sale

100

45.265

Common Stock

Sale

834

45.27

Common Stock

Sale

100

45.275

Common Stock

Sale

1086

45.28

Common Stock

Sale

100

45.285

Common Stock

Sale

934

45.29

Common Stock

Sale

300

45.295

Common Stock

Sale

1804

45.3

Common Stock

Sale

100

45.305

Common Stock

Sale

1407

45.31

Common Stock

Sale

300

45.315

Common Stock

Sale

1524

45.32

Common Stock

Sale

350

45.33

Common Stock

Sale

416

45.34

Common Stock

Sale

209

45.35

Common Stock

Sale

281

45.36

Common Stock

Sale

34712

45.37

Common Stock

Sale

119

45.39

Common Stock

Sale

100

45.46

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. call option

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of securities

Exercise price per unit (USD)

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (USD)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

0

0

0

0

0

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

0

0

0

0

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

18-06-2024

Contact name:

Stuart Brown

Telephone number:

00442070722969

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Full name of person making disclosure:

Qube Research & Technologies Limited

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

International Paper Company

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Common Stock

Put Option

IP US 07/19/24 P40 Equity

Written

60,000

USD 40

American

07/19/24

Common Stock

Call option

IP US 09/20/24 C50 Equity

Purchase

120,000

USD 50

American

09/20/24

Common Stock

Put Option

IP US07/19/24 P37.5 Equity

Written

60,000

USD 37.5

American

07/19/24

Common Stock

Put Option

IP US 07/19/24 P40 Equity

Written

140,000

USD 40

American

07/19/24

Common Stock

Call Option

IP US 09/20/24 C50 Equity

Purchase

280,000

USD 50

American

09/20/24

Common Stock

Put Option

IP US 07/19/24 P37.5 Equity

Written

140,000

USD 37.5

American

07/19/24

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Category Code: RET
Sequence Number: 1236111
Time of Receipt (offset from UTC): 20240618T132633+0100

Contacts

Qube Research & Technologies LTD

Contacts

Qube Research & Technologies LTD